▶ 調査レポート

抗菌ペプチドの世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Antimicrobial Peptides Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。抗菌ペプチドの世界市場2020年:メーカー別、地域別、種類・用途別 / Global Antimicrobial Peptides Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / MRC2012A0566資料のイメージです。• レポートコード:MRC2012A0566
• 出版社/出版日:GlobalInfoResearch / 2020年12月21日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、抗菌ペプチドの世界市場を広く調査・分析し、今後の市場展望をまとめております。抗菌ペプチドの種類別市場規模(植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド)、用途別市場規模(医薬品、飼料添加物、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):AnaSpec、Hycult Biotech、Novabiotics、AMP Biotech、GenScript、Phoenix Biotech、Ruixing Biotechnology、Ontores、Chinese Peptide、Sunsmile、Zhongnong Yingtai Biotechnology、Glam Technology、
・地域別グローバル市場分析 2015年-2020年
・抗菌ペプチドの北米市場(アメリカ、カナダ、メキシコ)
・抗菌ペプチドのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・抗菌ペプチドのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・抗菌ペプチドの南米市場(ブラジル、アルゼンチン)
・抗菌ペプチドの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド
・用途別分析:医薬品、飼料添加物、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Antimicrobial Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Antimicrobial Peptides market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 6 million by 2025, from USD 5 million in 2019.

Market segmentation
Antimicrobial Peptides market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Antimicrobial Peptides market has been segmented into
Plant Antimicrobial Peptides
Bacterial Antimicrobial Peptides
Animal Antimicrobial Peptides

By Application, Antimicrobial Peptides has been segmented into:
Pharmaceuticals
Feed Additives
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antimicrobial Peptides market presented in the report. This section sheds light on the sales growth of different regional and country-level Antimicrobial Peptides markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antimicrobial Peptides market.

The report offers in-depth assessment of the growth and other aspects of the Antimicrobial Peptides market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Antimicrobial Peptides Market Share Analysis
Antimicrobial Peptides competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antimicrobial Peptides sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antimicrobial Peptides sales, revenue and market share for each player covered in this report.

The major players covered in Antimicrobial Peptides are:
AnaSpec
Hycult Biotech
Novabiotics
AMP Biotech
GenScript
Phoenix Biotech
Ruixing Biotechnology
Ontores
Chinese Peptide
Sunsmile
Zhongnong Yingtai Biotechnology
Glam Technology

Among other players domestic and global, Antimicrobial Peptides market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antimicrobial Peptides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antimicrobial Peptides, with price, sales, revenue and global market share of Antimicrobial Peptides in 2018 and 2019.
Chapter 3, the Antimicrobial Peptides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antimicrobial Peptides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antimicrobial Peptides market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antimicrobial Peptides sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Antimicrobial Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antimicrobial Peptides Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Plant Antimicrobial Peptides
1.2.3 Bacterial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Market Analysis by Application
1.3.1 Overview: Global Antimicrobial Peptides Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Overview of Global Antimicrobial Peptides Market
1.4.1 Global Antimicrobial Peptides Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AnaSpec
2.1.1 AnaSpec Details
2.1.2 AnaSpec Major Business
2.1.3 AnaSpec SWOT Analysis
2.1.4 AnaSpec Product and Services
2.1.5 AnaSpec Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hycult Biotech
2.2.1 Hycult Biotech Details
2.2.2 Hycult Biotech Major Business
2.2.3 Hycult Biotech SWOT Analysis
2.2.4 Hycult Biotech Product and Services
2.2.5 Hycult Biotech Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novabiotics
2.3.1 Novabiotics Details
2.3.2 Novabiotics Major Business
2.3.3 Novabiotics SWOT Analysis
2.3.4 Novabiotics Product and Services
2.3.5 Novabiotics Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AMP Biotech
2.4.1 AMP Biotech Details
2.4.2 AMP Biotech Major Business
2.4.3 AMP Biotech SWOT Analysis
2.4.4 AMP Biotech Product and Services
2.4.5 AMP Biotech Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GenScript
2.5.1 GenScript Details
2.5.2 GenScript Major Business
2.5.3 GenScript SWOT Analysis
2.5.4 GenScript Product and Services
2.5.5 GenScript Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Phoenix Biotech
2.6.1 Phoenix Biotech Details
2.6.2 Phoenix Biotech Major Business
2.6.3 Phoenix Biotech Product and Services
2.6.4 Phoenix Biotech Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ruixing Biotechnology
2.7.1 Ruixing Biotechnology Details
2.7.2 Ruixing Biotechnology Major Business
2.7.3 Ruixing Biotechnology Product and Services
2.7.4 Ruixing Biotechnology Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Ontores
2.8.1 Ontores Details
2.8.2 Ontores Major Business
2.8.3 Ontores Product and Services
2.8.4 Ontores Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Chinese Peptide
2.9.1 Chinese Peptide Details
2.9.2 Chinese Peptide Major Business
2.9.3 Chinese Peptide Product and Services
2.9.4 Chinese Peptide Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sunsmile
2.10.1 Sunsmile Details
2.10.2 Sunsmile Major Business
2.10.3 Sunsmile Product and Services
2.10.4 Sunsmile Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Zhongnong Yingtai Biotechnology
2.11.1 Zhongnong Yingtai Biotechnology Details
2.11.2 Zhongnong Yingtai Biotechnology Major Business
2.11.3 Zhongnong Yingtai Biotechnology Product and Services
2.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Glam Technology
2.12.1 Glam Technology Details
2.12.2 Glam Technology Major Business
2.12.3 Glam Technology Product and Services
2.12.4 Glam Technology Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antimicrobial Peptides Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antimicrobial Peptides Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antimicrobial Peptides Manufacturer Market Share in 2019
3.3.2 Top 6 Antimicrobial Peptides Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antimicrobial Peptides Sales, Revenue and Market Share by Regions
4.1.1 Global Antimicrobial Peptides Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antimicrobial Peptides Revenue and Market Share by Regions (2015-2020)
4.2 North America Antimicrobial Peptides Sales and Growth Rate (2015-2020)
4.3 Europe Antimicrobial Peptides Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antimicrobial Peptides Sales and Growth Rate (2015-2020)
4.5 South America Antimicrobial Peptides Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antimicrobial Peptides Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antimicrobial Peptides Sales, Revenue and Market Share by Country
5.1.1 North America Antimicrobial Peptides Sales and Market Share by Country (2015-2020)
5.1.2 North America Antimicrobial Peptides Revenue and Market Share by Country (2015-2020)
5.2 United States Antimicrobial Peptides Sales and Growth Rate (2015-2020)
5.3 Canada Antimicrobial Peptides Sales and Growth Rate (2015-2020)
5.4 Mexico Antimicrobial Peptides Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antimicrobial Peptides Sales, Revenue and Market Share by Country
6.1.1 Europe Antimicrobial Peptides Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antimicrobial Peptides Revenue and Market Share by Country (2015-2020)
6.2 Germany Antimicrobial Peptides Sales and Growth Rate (2015-2020)
6.3 UK Antimicrobial Peptides Sales and Growth Rate (2015-2020)
6.4 France Antimicrobial Peptides Sales and Growth Rate (2015-2020)
6.5 Russia Antimicrobial Peptides Sales and Growth Rate (2015-2020)
6.6 Italy Antimicrobial Peptides Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antimicrobial Peptides Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antimicrobial Peptides Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antimicrobial Peptides Revenue and Market Share by Regions (2015-2020)
7.2 China Antimicrobial Peptides Sales and Growth Rate (2015-2020)
7.3 Japan Antimicrobial Peptides Sales and Growth Rate (2015-2020)
7.4 Korea Antimicrobial Peptides Sales and Growth Rate (2015-2020)
7.5 India Antimicrobial Peptides Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antimicrobial Peptides Sales and Growth Rate (2015-2020)
7.7 Australia Antimicrobial Peptides Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antimicrobial Peptides Sales, Revenue and Market Share by Country
8.1.1 South America Antimicrobial Peptides Sales and Market Share by Country (2015-2020)
8.1.2 South America Antimicrobial Peptides Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antimicrobial Peptides Sales and Growth Rate (2015-2020)
8.3 Argentina Antimicrobial Peptides Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antimicrobial Peptides Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antimicrobial Peptides Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antimicrobial Peptides Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antimicrobial Peptides Sales and Growth Rate (2015-2020)
9.3 Turkey Antimicrobial Peptides Sales and Growth Rate (2015-2020)
9.4 Egypt Antimicrobial Peptides Sales and Growth Rate (2015-2020)
9.5 South Africa Antimicrobial Peptides Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antimicrobial Peptides Sales and Market Share by Type (2015-2020)
10.2 Global Antimicrobial Peptides Revenue and Market Share by Type (2015-2020)
10.3 Global Antimicrobial Peptides Price by Type (2015-2020)
11 Global Antimicrobial Peptides Market Segment by Application
11.1 Global Antimicrobial Peptides Sales Market Share by Application (2015-2020)
11.2 Global Antimicrobial Peptides Revenue Market Share by Application (2015-2020)
11.3 Global Antimicrobial Peptides Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antimicrobial Peptides Sales, Revenue and Growth Rate (2021-2025)
12.2 Antimicrobial Peptides Market Forecast by Regions (2021-2025)
12.2.1 North America Antimicrobial Peptides Market Forecast (2021-2025)
12.2.2 Europe Antimicrobial Peptides Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antimicrobial Peptides Market Forecast (2021-2025)
12.2.4 South America Antimicrobial Peptides Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antimicrobial Peptides Market Forecast (2021-2025)
12.3 Antimicrobial Peptides Market Forecast by Type (2021-2025)
12.3.1 Global Antimicrobial Peptides Sales Forecast by Type (2021-2025)
12.3.2 Global Antimicrobial Peptides Market Share Forecast by Type (2021-2025)
12.4 Antimicrobial Peptides Market Forecast by Application (2021-2025)
12.4.1 Global Antimicrobial Peptides Sales Forecast by Application (2021-2025)
12.4.2 Global Antimicrobial Peptides Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Antimicrobial Peptides Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antimicrobial Peptides by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antimicrobial Peptides Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Antimicrobial Peptides Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. AnaSpec Basic Information, Manufacturing Base and Competitors
Table 9. AnaSpec Antimicrobial Peptides Major Business
Table 10. AnaSpec Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 11. AnaSpec SWOT Analysis
Table 12. AnaSpec Antimicrobial Peptides Product and Services
Table 13. AnaSpec Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Hycult Biotech Basic Information, Manufacturing Base and Competitors
Table 15. Hycult Biotech Antimicrobial Peptides Major Business
Table 16. Hycult Biotech Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 17. Hycult Biotech SWOT Analysis
Table 18. Hycult Biotech Antimicrobial Peptides Product and Services
Table 19. Hycult Biotech Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Novabiotics Basic Information, Manufacturing Base and Competitors
Table 21. Novabiotics Antimicrobial Peptides Major Business
Table 22. Novabiotics Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 23. Novabiotics SWOT Analysis
Table 24. Novabiotics Antimicrobial Peptides Product and Services
Table 25. Novabiotics Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. AMP Biotech Basic Information, Manufacturing Base and Competitors
Table 27. AMP Biotech Antimicrobial Peptides Major Business
Table 28. AMP Biotech Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 29. AMP Biotech SWOT Analysis
Table 30. AMP Biotech Antimicrobial Peptides Product and Services
Table 31. AMP Biotech Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. GenScript Basic Information, Manufacturing Base and Competitors
Table 33. GenScript Antimicrobial Peptides Major Business
Table 34. GenScript Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 35. GenScript SWOT Analysis
Table 36. GenScript Antimicrobial Peptides Product and Services
Table 37. GenScript Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Phoenix Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Phoenix Biotech Antimicrobial Peptides Major Business
Table 40. Phoenix Biotech Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 41. Phoenix Biotech SWOT Analysis
Table 42. Phoenix Biotech Antimicrobial Peptides Product and Services
Table 43. Phoenix Biotech Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Ruixing Biotechnology Basic Information, Manufacturing Base and Competitors
Table 45. Ruixing Biotechnology Antimicrobial Peptides Major Business
Table 46. Ruixing Biotechnology Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 47. Ruixing Biotechnology SWOT Analysis
Table 48. Ruixing Biotechnology Antimicrobial Peptides Product and Services
Table 49. Ruixing Biotechnology Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Ontores Basic Information, Manufacturing Base and Competitors
Table 51. Ontores Antimicrobial Peptides Major Business
Table 52. Ontores Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 53. Ontores SWOT Analysis
Table 54. Ontores Antimicrobial Peptides Product and Services
Table 55. Ontores Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Chinese Peptide Basic Information, Manufacturing Base and Competitors
Table 57. Chinese Peptide Antimicrobial Peptides Major Business
Table 58. Chinese Peptide Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 59. Chinese Peptide SWOT Analysis
Table 60. Chinese Peptide Antimicrobial Peptides Product and Services
Table 61. Chinese Peptide Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Sunsmile Basic Information, Manufacturing Base and Competitors
Table 63. Sunsmile Antimicrobial Peptides Major Business
Table 64. Sunsmile Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 65. Sunsmile SWOT Analysis
Table 66. Sunsmile Antimicrobial Peptides Product and Services
Table 67. Sunsmile Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Zhongnong Yingtai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 69. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Major Business
Table 70. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 71. Zhongnong Yingtai Biotechnology SWOT Analysis
Table 72. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product and Services
Table 73. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Glam Technology Basic Information, Manufacturing Base and Competitors
Table 75. Glam Technology Antimicrobial Peptides Major Business
Table 76. Glam Technology Antimicrobial Peptides Total Revenue (USD Million) (2018-2019)
Table 77. Glam Technology SWOT Analysis
Table 78. Glam Technology Antimicrobial Peptides Product and Services
Table 79. Glam Technology Antimicrobial Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Global Antimicrobial Peptides Sales by Manufacturer (2018-2019) (Mg)
Table 81. Global Antimicrobial Peptides Revenue by Manufacturer (2018-2019) (USD Million)
Table 82. Global Antimicrobial Peptides Sales by Regions (2015-2020) (Mg)
Table 83. Global Antimicrobial Peptides Sales Market Share by Regions (2015-2020)
Table 84. Global Antimicrobial Peptides Revenue by Regions (2015-2020) (USD Million)
Table 85. North America Antimicrobial Peptides Sales by Countries (2015-2020) (Mg)
Table 86. North America Antimicrobial Peptides Sales Market Share by Countries (2015-2020)
Table 87. North America Antimicrobial Peptides Revenue by Countries (2015-2020) (USD Million)
Table 88. North America Antimicrobial Peptides Revenue Market Share by Countries (2015-2020)
Table 89. Europe Antimicrobial Peptides Sales by Countries (2015-2020) (Mg)
Table 90. Europe Antimicrobial Peptides Sales Market Share by Countries (2015-2020)
Table 91. Europe Antimicrobial Peptides Revenue by Countries (2015-2020) (USD Million)
Table 92. Asia-Pacific Antimicrobial Peptides Sales by Regions (2015-2020) (Mg)
Table 93. Asia-Pacific Antimicrobial Peptides Sales Market Share by Regions (2015-2020)
Table 94. Asia-Pacific Antimicrobial Peptides Revenue by Regions (2015-2020) (USD Million)
Table 95. South America Antimicrobial Peptides Sales by Countries (2015-2020) (Mg)
Table 96. South America Antimicrobial Peptides Sales Market Share by Countries (2015-2020)
Table 97. South America Antimicrobial Peptides Revenue by Countries (2015-2020) (USD Million)
Table 98. South America Antimicrobial Peptides Revenue Market Share by Countries (2015-2020)
Table 99. Middle East & Africa Antimicrobial Peptides Sales by Countries (2015-2020) (Mg)
Table 100. Middle East & Africa Antimicrobial Peptides Sales Market Share by Countries (2015-2020)
Table 101. Middle East & Africa Antimicrobial Peptides Revenue by Countries (2015-2020) (USD Million)
Table 102. Middle East & Africa Antimicrobial Peptides Revenue Market Share by Countries (2015-2020)
Table 103. Global Antimicrobial Peptides Sales by Type (2015-2020) (Mg)
Table 104. Global Antimicrobial Peptides Sales Share by Type (2015-2020)
Table 105. Global Antimicrobial Peptides Revenue by Type (2015-2020) (USD Million)
Table 106. Global Antimicrobial Peptides Revenue Share by Type (2015-2020)
Table 107. Global Antimicrobial Peptides Sales by Application (2015-2020) (Mg)
Table 108. Global Antimicrobial Peptides Sales Share by Application (2015-2020)
Table 109. Global Antimicrobial Peptides Sales Forecast by Regions (2021-2025) (Mg)
Table 110. Global Antimicrobial Peptides Market Share Forecast by Regions (2021-2025)
Table 111. Global Antimicrobial Peptides Sales Forecast by Type (2021-2025) (Mg)
Table 112. Global Antimicrobial Peptides Market Share Forecast by Type (2021-2025)
Table 113. Global Antimicrobial Peptides Sales Forecast by Application (2021-2025)
Table 114. Global Antimicrobial Peptides Market Share Forecast by Application (2021-2025)
Table 115. Direct Channel Pros & Cons
Table 116. Indirect Channel Pros & Cons
Table 117. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antimicrobial Peptides Picture
Figure 2. Global Sales Market Share of Antimicrobial Peptides by Type in 2019
Figure 3. Plant Antimicrobial Peptides Picture
Figure 4. Bacterial Antimicrobial Peptides Picture
Figure 5. Animal Antimicrobial Peptides Picture
Figure 6. Antimicrobial Peptides Sales Market Share by Application in 2019
Figure 7. Pharmaceuticals Picture
Figure 8. Feed Additives Picture
Figure 9. Others Picture
Figure 10. Global Antimicrobial Peptides Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Antimicrobial Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Antimicrobial Peptides Sales Market Share by Manufacturer in 2019
Figure 31. Global Antimicrobial Peptides Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Antimicrobial Peptides Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Antimicrobial Peptides Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 36. Global Antimicrobial Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Antimicrobial Peptides Revenue Market Share by Regions (2015-2020)
Figure 38. Global Antimicrobial Peptides Revenue Market Share by Regions in 2018
Figure 39. North America Antimicrobial Peptides Sales and Growth Rate (2015-2020)
Figure 40. Europe Antimicrobial Peptides Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antimicrobial Peptides Sales and Growth Rate (2015-2020)
Figure 42. South America Antimicrobial Peptides Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Antimicrobial Peptides Sales and Growth Rate (2015-2020)
Figure 44. North America Antimicrobial Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Antimicrobial Peptides Sales Market Share by Countries (2015-2020)
Figure 46. North America Antimicrobial Peptides Sales Market Share by Countries in 2018
Figure 47. North America Antimicrobial Peptides Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Antimicrobial Peptides Revenue Market Share by Countries in 2018
Figure 49. United States Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 50. Canada Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 51. Mexico Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 52. Europe Antimicrobial Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Antimicrobial Peptides Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Antimicrobial Peptides Revenue Market Share by Countries in 2019
Figure 55. Germany Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 56. UK Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 57. France Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 58. Russia Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 59. Italy Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 60. Asia-Pacific Antimicrobial Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Antimicrobial Peptides Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Antimicrobial Peptides Revenue Market Share by Regions 2019
Figure 63. China Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 64. Japan Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 65. Korea Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 66. India Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 67. Southeast Asia Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 68. South America Antimicrobial Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Antimicrobial Peptides Sales Market Share by Countries in 2019
Figure 70. South America Antimicrobial Peptides Revenue Market Share by Countries in 2019
Figure 71. Brazil Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 72. Argentina Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 73. Middle East and Africa Antimicrobial Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Antimicrobial Peptides Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 78. Egypt Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 79. Turkey Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 80. South Africa Antimicrobial Peptides Sales and Growth Rate (2015-2020) (Mg)
Figure 81. Global Antimicrobial Peptides Sales and Growth Rate (2021-2025) (Mg)
Figure 82. Global Antimicrobial Peptides Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Antimicrobial Peptides Market Forecast (2021-2025) (Mg)
Figure 84. Europe Sales Antimicrobial Peptides Market Forecast (2021-2025) (Mg)
Figure 85. Asia-Pacific Sales Antimicrobial Peptides Market Forecast (2021-2025) (Mg)
Figure 86. South America Sales Antimicrobial Peptides Market Forecast (2021-2025) (Mg)
Figure 87. Middle East & Africa Sales Antimicrobial Peptides Market Forecast (2021-2025) (Mg)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel